The mounting rate of chronic diseases, bone damages (hip/knee), expanding number of obesity patients, increasing trauma/accidental cases and government funding for subsidizing to develop and improvise new surgical sealants and hemostats and expanding healthcare expenditure consumption are the central point driving growth of the hemostats and tissue sealants market in the Asia Pacific region during the forecast period. The Asia Pacific Hemostats and Tissue Sealants Market has been estimated to be growing at 9.65% CAGR and is predicted to reach $ xx million by 2027.
ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027
Asia Pacific Hemostats and Tissue Sealants Market by Products (Topical Hemostat (Mechanical Hemostats, Active Hemostats, Flowable Hemostats) Adhesive and Tissue Sealants (Synthetic Tissue Sealant, Oxidized Regenerated Cellulose, Cyanoacrylate Adhesives, Other Synthetic Tissue Sealants) Natural Tissue Sealant( Chitin and Chitosan Based Hemostatic Agent, Other Natural Tissue Sealant, Adhesion Barrier Products & by Geography.
The mounting rate of chronic diseases, bone damages (hip/knee), expanding number of obesity patients, increasing trauma/accidental cases and government funding for subsidizing to develop and improvise new surgical sealants and hemostats and expanding healthcare expenditure consumption are the central point driving growth of the hemostats and tissue sealants market in the Asia Pacific region during the forecast period. The Asia Pacific Hemostats and Tissue Sealants Market has been estimated to be growing at 9.65% CAGR and is predicted to reach $ xx million by 2027.
China, India, Japan, Australia, South Korea & countries from the Rest of Asia Pacific region are taken into consideration to make estimates and prediction on the trends of the hemostats and tissue sealants market. To obtain the manufacturing license and regulatory approval is made relatively easy in the Asia Pacific market. So, new startups can effortlessly begin their developments with the help of government funding in the emerging economies of Asia Pacific. Japan is found to hold the largest share for the market by revenue reasoned mainly to the rising levels of awareness regarding the use of such medical agents to avoid thrombosis & other critical postoperative complications. Also, there has been heavy development of healthcare infrastructure in the country which has propelled the market growth.
Advanced Medical Solutions (AMS) Group PLC, Baxter International Inc., B.Braun Melsungen AG, Cohera Medical Inc., Cryolife Inc., CSL Behring, Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Johnson & Johnson, Medtronic PLC, Pfizer, Inc., Smith & Nephew PLC and C.R. Bard, Inc. are the corporation and healthcare industries who are trading and supplying in the said market.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
- SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- INCREASING INCIDENCE OF CHRONIC DISEASES
- INCREASE IN AGING POPULATION
- INCREASE IN NUMBER OF SURGERIES
- MARKET RESTRAINTS
- STRINGENT REGULATIONS
- ADVERSE REACTIONS AND COMPLICATIONS
- MARKET OPPORTUNITIES
- USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
- ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
- MARKET CHALLENGES
- LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
- PRODUCT SIDE EFFECTS AND FDA SCRUTINY
- MARKET BY PRODUCTS
- TOPICAL HEMOSTAT
- MECHANICAL HEMOSTATS
- ACTIVE HEMOSTATS
- FLOWABLE HEMOSTATS
- ADHESIVE AND TISSUE SEALANTS
- SYNTHETIC TISSUE SEALANT
- OXIDIZED REGENERATED CELLULOSE
- CYANOACRYLATE ADHESIVES
- OTHER SYNTHETIC TISSUE SEALANTS
- NATURAL TISSUE SEALANT
- CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
- OTHER NATURAL TISSUE SEALANT
- ADHESION BARRIER PRODUCTS
- SYNTHETIC TISSUE SEALANT
- TOPICAL HEMOSTAT
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF BUYERS
- THREAT OF COMPETITIVE RIVALRY
- POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SWOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
- POLITICAL & LEGAL
- ECONOMIC
- TECHNOLOGICAL
- MARKET TRENDS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- BAXTER INTERNATIONAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BRAUN MELSUNGEN AG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC ANALYSIS
- COHERA MEDICAL INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- R. BARD, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CRYOLIFE INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- CSL BEHRING
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- INTEGRA LIFESCIENCES CORP
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- JOHNSON AND JOHNSON
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- MEDTRONIC PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- PFIZER, INC.
- COMPANY PROFILES
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SMITH AND NEPHEW PLC
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- ZIMMER BIOMET HOLDINGS INC
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
LIST OF TABLES
TABLE 1 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)
LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 19 CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 22 SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 23 REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- JAPAN
- CHINA
- INDIA
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- MARKET BY PRODUCTS
- TOPICAL HEMOSTAT
- MECHANICAL HEMOSTATS
- ACTIVE HEMOSTATS
- FLOWABLE HEMOSTATS
- ADHESIVE AND TISSUE SEALANTS
- SYNTHETIC TISSUE SEALANT
- OXIDIZED REGENERATED CELLULOSE
- CYANOACRYLATE ADHESIVES
- OTHER SYNTHETIC TISSUE SEALANTS
- NATURAL TISSUE SEALANT
- CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
- OTHER NATURAL TISSUE SEALANT
- ADHESION BARRIER PRODUCTS
- SYNTHETIC TISSUE SEALANT
- TOPICAL HEMOSTAT
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.